Comprehensive biodefense text published
A new book, Biological Weapons Defense: Infectious Disease and Counterbioterrorism, deals with the intentional causality of disease. Published by Humana Press, this text is also available in e-Book. Many of the contributors come from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the nation's premier biodefense laboratory. In this 624-page, hardcover text edite...First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
Chicken-produced antibodies demonstrate enhanced cell killing compared to conventionally produced anti-cancer antibodies Origen Therapeutics today announced the first published scientific report of fully functional, human sequence monoclonal antibodies (mAbs) produced in chickens. The antibodies were expressed solely in the chicken oviduct and deposited into egg white in concentrations of...Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells
Engineering the "Fc" region of monoclonal antibodies (mAbs) increases their toxicity to cancer cells, potentially improving the utility of targeted cancer therapies, according to research conducted at Xencor, which will be published in the March 14 print issue of the Proceedings of the National Academy of Sciences (PNAS). Monoclonal antibodies have important advantages over chemotherapy a...Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) is pleased to announce that Neurobiology of Aging, one of the world's leading peer-reviewed medical journals in the fields of gerontology and neuroscience, has published an online version of a publication on the preclinical development of tramiprosate (3-amino-1-propanesulfonic acid; Alzhemed?, including efficacy results in a mouse model of brain amyloidosi...Combating anthrax: Results of study published this month as researchers look for a better vaccine
A new study published this month by a Saint Louis University vaccine researcher scrutinizes what in the future could be an alternative to the presently available anthrax vaccine. In its first human testing, the vaccine was given to...A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
Dr. Elizabeth Kavaler has claimed that her new book that has just been realised would help women in understanding and identifying their urinary tract disorder. // The author, who is also a practising urologist, has said that many women are usually frequent visitors to the public toilet in their community, while many plan their outing with necessary visits to the toilets. She is of the op...Findings on Dangerous Parasite, Toxoplasma Gondii Published
Montana State University researchers and their collaborators are gaining widespread attention for discoveries involving// a common parasite that can threaten everyone from babies to AIDS patients. Their findings about Toxoplasma gondii and toxoplasmosis were published recently in three major scientific journals. Nature published a paper in its advanced online version. "I...Siddha Medicine Texts to Be Published in English
A project to translate the ancient Tamil texts of Siddha system of medicine into English is on the verge of completion. // One set of translations from the texts, contained in palm leaf manuscripts, would be published soon, according to Arcot N.Veerasamy, a senior minister in the southern Indian state of Tamil Nadu. As many as six Sidha practitioners have worked on a Rs.5...Largest Ever Study of Genetics Behind Common Diseases Published
The largest ever study of the genetics behind common diseaseslike diabetes, rheumatoid arthritis, and coronary heart diseasehas been published in the journals Nature and Nature Genetics. The nine-million-pound Wellcome Trust Case Control Consortium is one of the UKs largest and most successful academic collaborations to date, which brought together 50 leading research groups and 20...VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Jun 25, 2007 - VIVUS, Inc.(NASDAQ: VVUS), a pharmaceutical company dedicated to thedevelopment and commercialization of novel therapeutic products,announced that Abstract #2209-PO, Evaluation of Glycemic Parametersin Obese Diabetic Patients Treated with Phentermine and Topiramate:Outcomes in a Private Practice Setting has been published in theAmerican...